Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read General business news Saregama delivers record Rs 11,713m FY25 revenue amid aggressive IP investments and digital expansion Find out how Saregama posted record ₹11,713 Mn revenue in FY25 with sharp digital expansion, IP acquisition, and licensing growth. byPallavi MadhirajuMay 15, 2025